Northern Trust’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $103M | Buy |
1,112,439
+9,648
| +0.9% | +$969K | 0.01% | 726 |
|
|
2025
Q4 | $113M | Sell |
1,102,791
-51,970
| -5% | -$4.65M | 0.01% | 693 |
|
|
2025
Q3 | $72.1M | Sell |
1,154,761
-29,042
| -2% | -$1.58M | 0.01% | 902 |
|
|
2025
Q2 | $61.6M | Sell |
1,183,803
-93,477
| -7% | -$4.17M | 0.01% | 966 |
|
|
2025
Q1 | $54.4M | Buy |
1,277,280
+135,288
| +12% | +$5.84M | 0.01% | 1034 |
|
|
2024
Q4 | $34.9M | Buy |
1,141,992
+77,413
| +7% | +$2.18M | ﹤0.01% | 1354 |
|
|
2024
Q3 | $24.4M | Buy |
1,064,579
+31,672
| +3% | +$896K | ﹤0.01% | 1498 |
|
|
2024
Q2 | $29.8M | Sell |
1,032,907
-14,216
| -1% | -$331K | 0.01% | 1307 |
|
|
2024
Q1 | $21.6M | Sell |
1,047,123
-32,457
| -3% | -$696K | ﹤0.01% | 1541 |
|
|
2023
Q4 | $29.2M | Sell |
1,079,580
-24,108
| -2% | -$632K | 0.01% | 1358 |
|
|
2023
Q3 | $32.7M | Buy |
1,103,688
+22,548
| +2% | +$793K | 0.01% | 1215 |
|
|
2023
Q2 | $38.7M | Buy |
1,081,140
+641,525
| +146% | +$18.4M | 0.01% | 1134 |
|
|
2023
Q1 | $10.3M | Buy |
439,615
+11,997
| +3% | +$343K | ﹤0.01% | 1985 |
|
|
2022
Q4 | $11.6M | Buy |
427,618
+1,807
| +0.4% | +$82.7K | ﹤0.01% | 1903 |
|
|
2022
Q3 | $22.9M | Buy |
425,811
+5,191
| +1% | +$267K | 0.01% | 1374 |
|
|
2022
Q2 | $17M | Sell |
420,620
-259
| -0.1% | -$12.8K | ﹤0.01% | 1651 |
|
|
2022
Q1 | $27.9M | Sell |
420,879
-217
| -0.1% | -$14.8K | ﹤0.01% | 1436 |
|
|
2021
Q4 | $42.1M | Sell |
421,096
-1,961
| -0.5% | -$203K | 0.01% | 1232 |
|
|
2021
Q3 | $52.9M | Sell |
423,057
-1,210
| -0.3% | -$144K | 0.01% | 1035 |
|
|
2021
Q2 | $52.7M | Sell |
424,267
-19,437
| -4% | -$2.61M | 0.01% | 1096 |
|
|
2021
Q1 | $67.7M | Buy |
443,704
+8,978
| +2% | +$1.36M | 0.01% | 888 |
|
|
2020
Q4 | $56M | Buy |
434,726
+32,584
| +8% | +$3.75M | 0.01% | 985 |
|
|
2020
Q3 | $45M | Buy |
402,142
+47,620
| +13% | +$4.36M | 0.01% | 989 |
|
|
2020
Q2 | $28.8M | Buy |
354,522
+116,283
| +49% | +$9.37M | 0.01% | 1321 |
|
|
2020
Q1 | $16.6M | Buy |
238,239
+11,421
| +5% | +$876K | ﹤0.01% | 1543 |
|
|
2019
Q4 | $17.7M | Buy |
226,818
+8,885
| +4% | +$640K | ﹤0.01% | 1815 |
|
|
2019
Q3 | $13.9M | Sell |
217,933
-47,006
| -18% | -$4.14M | ﹤0.01% | 1938 |
|
|
2019
Q2 | $22.9M | Buy |
264,939
+70,273
| +36% | +$5.37M | 0.01% | 1589 |
|
|
2019
Q1 | $14.9M | Buy |
194,666
+571
| +0.3% | +$31.7K | ﹤0.01% | 1889 |
|
|
2018
Q4 | $7.3M | Buy |
+194,095
| New | +$7.15M | ﹤0.01% | 2277 |
|
Other funds holding GH
VPM
VCM
Northern Trust's GH Position: Q1 2026 in Review
Northern Trust increased its Guardant Health (GH) stake by 0.87% in Q1 2026, buying an estimated $969K and bringing the position to 1,112,439 shares worth $103M. The position accounts for 0.01% of the portfolio, ranked #726.
Northern Trust first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $113M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.
- Northern Trust held 1,112,439 shares of Guardant Health worth $103M as of Q1 2026.
- Northern Trust bought 9,648 Guardant Health shares in Q1 2026, an estimated $969K.
- Guardant Health made up 0.01% of Northern Trust's portfolio in Q1 2026, its #726 holding.
- Northern Trust first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
- Northern Trust's Guardant Health position peaked at $113M in Q4 2025.
- 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.